Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Which Is Cheaper Index Fund Or Active Fund? Understanding expense ratios and trading costs helps you choose the cheaper option over the long run.
23,513 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Retirees face a shifting rate landscape. This guide explains how a possible 2026 rate rise could affect income, withd...
If you’re chasing steady income, the default move isn’t always the highest yield. This guide explains why a dividend ...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Stocks with dividends are drawing buyers as growth slows. HDV and SPYD command big flows, yet risk signals suggest on...
Spot Bitcoin ETFs are drawing record flows in 2026, with IBIT and FBTC leading liquidity. Here’s how to pick which bi...
Bloom Energy surged to the forefront in 2026 with double-digit gains and a massive market cap, while FuelCell Energy ...
With crude hovering near $70, some investors wonder if energy stocks can keep delivering. This article explains why t...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
A $2.9 billion closed-end fund has paid distributions every year since 2000, marking a 26-year streak. Here’s how the...
A looming funding gap in Social Security invites tough questions for your retirement. This guide explains what insolv...
Institutional funds often reveal conviction through large stake increases. This article explains the implications whe...